US Brucellosis Market Research Report: By species (Brucella suis, B. abortus, B. melitensis) - Forecast to 2035

US Brucellosis Market Overview

As per MRFR analysis, the US Brucellosis Market Size was estimated at 59.78 (USD Million) in 2023. The US Brucellosis Market Industry is expected to grow from 65.1 (USD Million) in 2024 to 141 (USD Million) by 2035. The US Brucellosis Market CAGR (growth rate) is expected to be around 7.278% during the forecast period (2025 - 2035).

Key Trends in the US Brucellosis Market

The US Brucellosis Market is witnessing significant trends driven by changes in industry practices and public health awareness. Increasing cases of brucellosis among livestock have heightened concerns about food safety and public health, leading to government initiatives focused on disease control and prevention. Regulatory frameworks along with stringent monitoring mechanisms are being implemented to manage brucellosis in cattle and farm animals effectively.

This regulatory attention acts as a key market driver, as both farmers and industry stakeholders are motivated to adopt preventive measures and vaccination programs to mitigate the economic losses associated with outbreaks. Additionally, heightened awareness related to zoonotic diseases is creating opportunities in the market. As consumers become more health-conscious, there is a growing demand for brucellosis-free meat and dairy products, which encourages producers to adopt more rigorous health standards.

The increased emphasis on biosecurity measures on farms provides a pivotal opportunity for the development of vaccines and diagnostic kits aimed specifically at brucellosis prevention. Recent trends show that advancements in veterinary diagnostics are leading to better disease management and control strategies. The use of modern technology like molecular diagnostics and automation in laboratories is improving the speed and accuracy of brucellosis testing.

Subsequently, educational programs aimed at farmers regarding brucellosis prevention are gaining traction, bolstering community engagement and reinforcing best practices in animal husbandry. This combination of scientific advancement and community awareness is expected to shape the future landscape of the US Brucellosis Market, aligning with broader public health goals and livestock management strategies.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Brucellosis Market Drivers

Increasing Incidence of Brucellosis in Livestock

The rising incidence of Brucellosis in livestock, particularly cattle and buffaloes, is a significant driver for the US Brucellosis Market Industry. According to the United States Department of Agriculture (USDA), there were over 100 reported cases of Brucellosis in bovine cattle in the past year alone. This prevalent occurrence necessitates increased monitoring and control measures, leading to an uptick in demand for diagnostic tests and vaccines.

Organizations like the American Veterinary Medical Association are actively involved in researching effective means to manage this disease, which impacts livestock health, consequently influencing the growth of the US Brucellosis Market Industry as farmers and veterinarians seek better solutions for prevention and treatment.

Government Initiatives and Funding for Disease Control

The US government has ramped up its efforts to control and eradicate Brucellosis, particularly in livestock, through various initiatives and funding programs. The USDA has allocated millions in grants specifically aimed at improving herd management and disease prevention strategies. These initiatives provide financial support for Research and Development (R&D) of new vaccines and diagnostic tools, contributing to market growth.

With the USDA reporting an increase in funding by 15% over the last five years for programs targeting livestock diseases, the US Brucellosis Market Industry is well-positioned to benefit from these increased investments, as they stimulate advancements in treatment methods and preventive measures.

Growth in Animal Health Awareness

There is a growing awareness regarding animal health in the US, including the implications of Brucellosis not just on livestock, but also on public health. Education campaigns led by organizations such as the Centers for Disease Control and Prevention (CDC) have highlighted the zoonotic nature of Brucellosis, where the disease can transfer from animals to humans, leading to flu-like symptoms and more severe complications.

This awareness has spurred farmers and ranchers to prioritize better health practices and vaccinations for their herds, driving demand within the US Brucellosis Market Industry. The CDC has noted an increase in requests for health-related workshops and training related to animal diseases, indicating a trend that can be leveraged for stronger market growth.

US Brucellosis Market Segment Insights

Brucellosis Market species Insights

The US Brucellosis Market exhibits a diverse segmentation based on species, each contributing distinctly to the overall dynamics of the industry. This segment includes Brucella suis, B. abortus, and B. melitensis, with each species relating to different host animals and associated pathology. B. abortus, primarily affecting cattle, is crucial in terms of livestock disease management, as its presence can significantly impact agricultural productivity and consequently the agricultural economy in the US.

The management of this species is vital for ensuring food safety and protecting public health, since cattle are a major source of livestock products consumed nationwide. B. melitensis, affecting sheep and goats, is significant as it poses risks not only to livestock health but also to human populations, particularly in individuals who engage in direct contact with infected animals or contaminated products.

This aspect elevates the importance of rigorous monitoring and control measures within the agricultural protocols. Lastly, Brucella suis, which primarily impacts swine, is notable not just for its effects on animal health but also for its implications on the broader meat market; controlling this strain is essential in maintaining the health of swine populations, which are pivotal in the US meat supply chain.

The understanding of these species and their unique characteristics informs research and development focused on vaccines and diagnostics, ultimately aiming to reduce the economic burden associated with brucellosis. Overall, the interplay between these species and their management strategies significantly influences market trends and presents opportunities for advancements in veterinary science, public health initiatives, and agricultural practices.

As health agencies and agricultural organizations continue to address brucellosis, the species-based segmentation remains a focal point in efforts to mitigate infectious diseases in both animals and humans across the United States.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Brucellosis Market Key Players and Competitive Insights

The competitive insights of the US Brucellosis Market reveal a landscape shaped by various players offering specialized solutions aimed at combating this zoonotic disease that affects livestock and can pose risks to human health. The market has been experiencing innovation in terms of diagnostic tools, vaccines, and therapeutic agents, catering to both animal health and food security concerns.

Competitive strategies among key participants encompass product differentiation, technological advancement, strategic alliances, and strong delivery networks. Companies consistently strive to secure a more substantial market share through ongoing research and development efforts, alongside collaborations with agricultural stakeholders to enhance the effectiveness of prevention and control measures against brucellosis.

Such dynamics create a robust environment where product efficacy, regulatory compliance, and market accessibility become crucial factors influencing competitive positioning. Elanco stands out within the US Brucellosis Market with a solid portfolio of products focused on animal health, particularly in the prevention and treatment of brucellosis in livestock.

Its commitment to research and development has enabled the company to deliver effective solutions tailored for veterinarians and farm operators seeking to manage and mitigate the risks associated with brucellosis. Elanco's established presence in the animal health sector is bolstered by its extensive distribution networks and strategic partnerships with veterinary professionals and organizations, ensuring that they remain a reliable source for effective brucellosis management solutions.

By leveraging its strengths in innovation and customer support, Elanco continues to maintain a competitive edge while effectively addressing the challenges posed by this disease in the US agricultural landscape. Vetoquinol is also a significant player in the US Brucellosis Market, providing a range of veterinary pharmaceuticals and vaccines specifically designed to combat this bovine disease.

The company's strengths lie in its commitment to quality and the development of effective health products, which cater to the specific needs of livestock producers. Vetoquinol's market presence is characterized by strong relationships with veterinarians and a deep understanding of the regulatory environment surrounding animal health in the US.

Their key products include vaccines that serve as a crucial line of defense against brucellosis, reinforcing animal health and farm productivity. Recently, Vetoquinol has pursued strategic mergers and acquisitions to enhance its product offerings and expand its operational capabilities.

These moves not only bolster their market position but also position Vetoquinol as a formidable competitor in addressing brucellosis through continuous innovation and a focused approach to customer needs within the animal health sector in the US.

Key Companies in the US Brucellosis Market Include

• Elanco


• Vetoquinol


• Heska


• Arata Exotics


• Zoetis


• Merck Animal Health


• VetTech


• Boehringer Ingelheim


• AgriLabs


• Patterson Companies


• Valley Vet Supply


• Neogen


• Huvepharma


• Ceva Santé Animale


• Intervet

US Brucellosis Market Industry Developments

Recent developments in the US Brucellosis Market indicate a growing focus on vaccination and prevention strategies to combat this zoonotic disease, primarily in cattle and bison herds. Companies such as Elanco, Zoetis, and Merck Animal Health are actively enhancing their vaccination offerings and developing more effective diagnostic tools to reduce Brucellosis prevalence.

In recent months, additional investment in Research and Development has been noted, particularly by Vetoquinol and Heska, reflecting a broader industry trend towards innovation in livestock health management. Noteworthy happenings include a significant rise in market valuation driven by increased demand for animal health products, revealing a compound annual growth rate that highlights the market's robust expansion.

In terms of mergers and acquisitions, no recent activities involving the specified companies have been reported, yet the market remains dynamic with various strategic collaborations anticipated. Over the last few years, the USDA has emphasized eradication efforts, strengthening regulatory frameworks to ensure the reduction of Brucellosis incidences.

The collective efforts of these companies, together with governmental initiatives, underscore the importance of maintaining animal health and addressing public health concerns associated with Brucellosis in the US.

US Brucellosis Market Segmentation Insights

Brucellosis Market species Outlook

• Brucella suis


• B. abortus


• B. melitensis

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	59.78(USD Million)
MARKET SIZE 2024	65.1(USD Million)
MARKET SIZE 2035	141.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.278% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Elanco, Vetoquinol, Heska, Arata Exotics, Zoetis, Merck Animal Health, VetTech, Boehringer Ingelheim, AgriLabs, Patterson Companies, Valley Vet Supply, Neogen, Huvepharma, Ceva Santé Animale, Intervet
SEGMENTS COVERED	species
KEY MARKET OPPORTUNITIES	Increased vaccination programs, Rapid diagnostic tests development, Rising zoonotic disease awareness, Strengthening regulatory frameworks, Expansion of telehealth services
KEY MARKET DYNAMICS	increasing prevalence of brucellosis, growing awareness among livestock owners, advancements in diagnostic technologies, government regulatory support, rising research funding and initiatives
COUNTRIES COVERED	US